Charles Schwab Investment Management Inc Amicus Therapeutics, Inc. Transaction History

Charles Schwab Investment Management Inc

  • $601 Billion
  • Q3 2025

A detailed history of Charles Schwab Investment Management Inc transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 2,752,098 shares of FOLD stock, worth $26.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,752,098
Previous 2,548,056 8.01%
Holding current value
$26.1 Million
Previous $14.6 Million 48.53%
% of portfolio
0.0%
Previous 0.0%

Shares

34 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 10, 2025
BUY
$5.84 - $8.57 $1.19 Million - $1.75 Million
204,042 Added 8.01%
2,752,098 $21.7 Million
Q2 2025

Aug 12, 2025
BUY
$5.64 - $8.0 $321,344 - $455,808
56,976 Added 2.29%
2,548,056 $14.6 Million
Q1 2025

Sep 15, 2025
SELL
$8.16 - $9.85 $464,924 - $561,213
-56,976 Reduced 2.24%
2,491,080 $20.3 Million
Q1 2025

May 09, 2025
SELL
$8.16 - $9.85 $781,099 - $942,871
-95,723 Reduced 3.7%
2,491,080 $20.3 Million
Q4 2024

Feb 06, 2025
SELL
$9.36 - $12.01 $753,180 - $966,420
-80,468 Reduced 3.02%
2,586,803 $24.4 Million
Q3 2024

Nov 12, 2024
BUY
$9.55 - $12.09 $2.32 Million - $2.93 Million
242,672 Added 10.01%
2,667,271 $28.5 Million
Q2 2024

Aug 12, 2024
BUY
$9.04 - $11.75 $882,954 - $1.15 Million
97,672 Added 4.2%
2,424,599 $24.1 Million
Q1 2024

May 08, 2024
BUY
$11.43 - $14.24 $663,408 - $826,503
58,041 Added 2.56%
2,326,927 $27.4 Million
Q4 2023

Feb 06, 2024
BUY
$9.97 - $14.52 $899,244 - $1.31 Million
90,195 Added 4.14%
2,268,886 $32.2 Million
Q3 2023

Nov 08, 2023
BUY
$11.78 - $13.86 $856,099 - $1.01 Million
72,674 Added 3.45%
2,178,691 $26.5 Million
Q2 2023

Aug 09, 2023
BUY
$10.72 - $13.3 $427,288 - $530,124
39,859 Added 1.93%
2,106,017 $26.5 Million
Q1 2023

May 11, 2023
BUY
$10.91 - $13.54 $10,637 - $13,201
975 Added 0.05%
2,066,158 $22.9 Million
Q4 2022

Feb 13, 2023
BUY
$9.89 - $12.7 $440,283 - $565,378
44,518 Added 2.2%
2,065,183 $25.2 Million
Q3 2022

Nov 14, 2022
BUY
$9.82 - $12.75 $319,434 - $414,744
32,529 Added 1.64%
2,020,665 $21.1 Million
Q2 2022

Aug 15, 2022
SELL
$6.23 - $11.12 $103,405 - $184,569
-16,598 Reduced 0.83%
1,988,136 $21.4 Million
Q1 2022

May 13, 2022
BUY
$7.89 - $12.48 $371,753 - $588,020
47,117 Added 2.41%
2,004,734 $19 Million
Q4 2021

Feb 11, 2022
BUY
$9.82 - $12.44 $851,236 - $1.08 Million
86,684 Added 4.63%
1,957,617 $22.6 Million
Q3 2021

Nov 16, 2021
SELL
$8.74 - $11.84 $1.81 Million - $2.46 Million
-207,571 Reduced 9.99%
1,870,933 $17.9 Million
Q2 2021

Aug 16, 2021
BUY
$8.71 - $10.72 $504,979 - $621,513
57,977 Added 2.87%
2,078,504 $20 Million
Q1 2021

May 17, 2021
BUY
$9.2 - $23.86 $1.13 Million - $2.92 Million
122,560 Added 6.46%
2,020,527 $20 Million
Q4 2020

Feb 16, 2021
BUY
$13.47 - $24.89 $61,665 - $113,946
4,578 Added 0.24%
1,897,967 $43.8 Million
Q3 2020

Nov 13, 2020
SELL
$12.89 - $15.89 $383,838 - $473,172
-29,778 Reduced 1.55%
1,893,389 $26.7 Million
Q2 2020

Aug 14, 2020
BUY
$8.86 - $15.69 $745,790 - $1.32 Million
84,175 Added 4.58%
1,923,167 $29 Million
Q1 2020

May 15, 2020
BUY
$6.63 - $11.16 $1.25 Million - $2.1 Million
188,216 Added 11.4%
1,838,992 $17 Million
Q4 2019

Feb 07, 2020
BUY
$7.48 - $10.75 $801,930 - $1.15 Million
107,210 Added 6.95%
1,650,776 $16.1 Million
Q3 2019

Nov 08, 2019
BUY
$8.02 - $13.25 $803,114 - $1.33 Million
100,139 Added 6.94%
1,543,566 $12.4 Million
Q2 2019

Aug 09, 2019
BUY
$10.96 - $14.4 $2.76 Million - $3.63 Million
251,854 Added 21.14%
1,443,427 $18 Million
Q1 2019

May 14, 2019
BUY
$10.04 - $13.92 $1.51 Million - $2.09 Million
150,212 Added 14.42%
1,191,573 $16.2 Million
Q4 2018

Feb 14, 2019
BUY
$8.38 - $13.44 $54,101 - $86,768
6,456 Added 0.62%
1,041,361 $9.98 Million
Q3 2018

Nov 13, 2018
BUY
$11.6 - $16.54 $532,428 - $759,169
45,899 Added 4.64%
1,034,905 $12.5 Million
Q2 2018

Aug 08, 2018
BUY
$13.13 - $17.09 $1.02 Million - $1.32 Million
77,388 Added 8.49%
989,006 $15.4 Million
Q1 2018

May 07, 2018
BUY
$13.76 - $17.12 $2.03 Million - $2.53 Million
147,843 Added 19.36%
911,618 $13.7 Million
Q4 2017

Jan 17, 2018
BUY
$12.51 - $16.24 $399,069 - $518,055
31,900 Added 4.36%
763,775 $11 Million
Q3 2017

Nov 13, 2017
BUY
$11.74 - $15.78 $8.59 Million - $11.5 Million
731,875
731,875 $11 Million

Others Institutions Holding FOLD

# of Institutions
322
Shares Held
323M
Call Options Held
1.09M
Put Options Held
1.04M
View Full List

About AMICUS THERAPEUTICS, INC.

FOLD Quotes by TradingView
  • Ticker FOLD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 280,497,984
  • Market Cap $2.66B
  • Description
  • Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...
More about FOLD
Track This Portfolio

Track Charles Schwab Investment Management Inc Portfolio

Follow Charles Schwab Investment Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email